Midatech Pharma PLC Announces Posting of Annual Report & Notice of AGM

Rhea-AI Summary

Midatech Pharma PLC has posted its Notice of Annual General Meeting (AGM) along with the Annual Report for the year ending December 31, 2020. The AGM is scheduled for June 30, 2021, at Oddfellows House, Cardiff, but shareholders are advised to participate via proxy due to COVID-19 precautions. The documents are available on the company's website. The AGM will address key issues and future plans as the company continues to navigate challenges posed by the pandemic.

ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 21, 2021 / Midatech Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces that its Notice of Annual General Meeting ("AGM") was posted to shareholders today, along with the Annual Report for the year ended 31 December 2020. The document is also available on the "Investors" section of the Company's website at www.midatechpharma.com/financial-reports-accounts.

The Company believes that, notwithstanding the current plan for the relaxation of Government restrictions on the holding of events due to COVID-19, a cautious approach is appropriate. Accordingly, while the Company will hold the 2021 AGM at its offices at 11.30am at Oddfellows House, 19 Newport Road, Cardiff CF24 0AA on 30 June 2021, shareholders are encouraged not to attend the AGM in person, but instead be represented by the Chair of the AGM acting as their proxy. Further details on how to vote by proxy are set out in the Notice of AGM.

For more information, please contact:

Midatech Pharma PLC

Stephen Stamp, CEO, CFO

Tel: +44 (0)29 20480180

www.midatechpharma.com

Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker)

Freddy Crossley, Emma Earl (Corporate Finance)

Rupert Dearden (Corporate Broking)

Tel: +44 (0)20 7886 2500 Turner Pope Investments (TPI) Limited (Joint Broker)

Andrew Thacker / James Pope (Corporate Broking)

Tel: +44(0)20 3657 0050

IFC Advisory Limited (Financial PR and UK Investor Relations)

Tim Metcalfe / Graham Herring

Tel: +44 (0)20 3934 6630

Email: midatech@investor-focus.co.uk

Edison Group (US Investor Relations) Megan Paul Tel: +1 (646) 653 7034 Email: mpaul@edisongroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Midatech Pharma PLC

View source version on accesswire.com:
https://www.accesswire.com/648570/Midatech-Pharma-PLC-Announces-Posting-of-Annual-Report-Notice-of-AGM

FAQ

When is Midatech Pharma's Annual General Meeting (AGM) scheduled?

The AGM is scheduled for June 30, 2021.

How can shareholders participate in the AGM for Midatech Pharma?

Shareholders are encouraged to vote by proxy and not attend in person due to COVID-19.

Where can I find the Annual Report for Midatech Pharma for 2020?

The Annual Report is available on Midatech Pharma's website in the Investors section.

What is the focus of Midatech Pharma as a company?

Midatech Pharma focuses on drug delivery technology to improve bio-delivery and bio-distribution of medicines.

What precautions is Midatech Pharma taking for the AGM due to COVID-19?

The company is advising shareholders to participate via proxy rather than attending in person.